eazyplex SARS-CoV-2: new molecular test within 25 minutes from Amplex Diagnostics
EMM Life Science now offers the new eazyplex® SARS-CoV-2 test from Amplex Diagnostics. This test can be run on two different instruments:
Genie® II with the possibility to run 1-2 tests at the same time and Genie® HT where you can run 1-12 tests at the same time. Both systems have random access.
eazyplex® SARS-CoV-2
- No RNA extraction required
- Analysis from oropharyngeal swab’s
- Controls for lysis and correct sampling
- Molecular response within 25 min
- 1-12 independent blocks (depending on instrument)
- Random access
- HIS / LIS compatible
eazyplex® SARS-CoV-2 may, for example, be used for testing staff in hospital or homes for elderly people as a possible more accurate method than antigen testing.
For sensitivity and specificity, see below evaluation of 200 patient samples at Jena University Hospital (Institute of Medical Microbiology, Prof. Dr. Rödel, Germany) Comparison was made to NeuMoDx SARS-CoV-2 Assay (NeuMoDx Molecular):
Sensitivity: | CT <22.2 | CT <25 | CT <28 | CT <30 | CT <40 |
100% | 100% | 97.6% | 84.2% | 72.6% |
Specificity: 100% (n = 200, 83 negative samples)
For more information, please contact us:
Henrik Mascher or Sara Nordgren at This email address is being protected from spambots. You need JavaScript enabled to view it. or +46 8 408 823 00.